Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps
Adeno-associated virus-based gene therapy for hemophilia has emerged as a revolutionary treatment option, offering potential correction of clotting factor deficiency through a single intravenous infusion of functional genes directed to hepatocytes. With 3 gene therapies recently approved, this appro...
Saved in:
Main Authors: | Wolfgang Miesbach, Paul Batty, Pratima Chowdary, Sylvia Fong, Radoslaw Kaczmarek, Frank W.G. Leebeek, Brian Long, Johnny Mahlangu, Mike Makris, Glenn F. Pierce, Steven W. Pipe, Alok Srivastava, Jan Voorberg, Flora Peyvandi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037924003686 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemophilia A Haplotypes in Southwestern Iran
by: Bizhen Keikhaei Dehdezi, et al.
Published: (2025-01-01) -
Difficulties the Conservative Treatment of Crohn’s Disease Complicated by Autoimmune Hemophilia A
by: E. L. Belyaeva, et al.
Published: (2020-01-01) -
Recombinant factor VIIa: new insights into the mechanism of action through product innovation
by: Miguel A. Escobar, et al.
Published: (2025-01-01) -
The changing landscape of treatment for acquired hemophilia A
by: Massimo Franchini, et al.
Published: (2025-01-01) -
Seroprevalence of hepatitis B and C virus among a group of hemophilia patients in Kurdistan Region, Iraq
by: Salih A. Hama
Published: (2025-02-01)